Healthcare & Life Sciences
HepaRegeniX
Germanyheparegenix.com/
HepaRegeniX is a series b startup based in Germany. 1 investor tracked.
Activeseries-b
series-b
Stage
2017
Founded
4
Investors
About HepaRegeniX
HepaRegeniX is a company founded in 2017 headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 4 investors associated with the company.
HepaRegeniX is a biopharmaceutical company developing novel small molecule therapeutics to stimulate liver regeneration. Their lead compound, HRX-215, targets the MKlp2 protein for the treatment of acute and chronic liver diseases.
Explore HepaRegeniX's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.